Growth inhibitory effects of interferon on blast cells from patients with acute myelogenous leukaemia.
作者信息
Rohatiner A Z
出版信息
Br J Cancer. 1984 Jun;49(6):805-7. doi: 10.1038/bjc.1984.125.
Abstract
摘要
相似文献
1
Growth inhibitory effects of interferon on blast cells from patients with acute myelogenous leukaemia.干扰素对急性髓性白血病患者原始细胞的生长抑制作用。
Br J Cancer. 1984 Jun;49(6):805-7. doi: 10.1038/bjc.1984.125.
2
Lack of prognostic value of the thymidine-labelling index in adult acute leukaemia.胸苷标记指数在成人急性白血病中缺乏预后价值。
Br J Cancer. 1981 Jul;44(1):55-62. doi: 10.1038/bjc.1981.147.
3
A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture.重组人干扰素α2和干扰素ω在人骨髓培养中的抗增殖特性比较。
J Interferon Cytokine Res. 1997 Jun;17(6):327-9. doi: 10.1089/jir.1997.17.327.
4
Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.正常及急性髓性白血病骨髓细胞对阿糖胞苷抑制作用的敏感性。
Br J Cancer. 1980 Jun;41(6):985-8. doi: 10.1038/bjc.1980.178.
5
Growth inhibitory effect of gene-cloned interferons on human myeloblast colonies.基因克隆干扰素对人成髓细胞集落的生长抑制作用
Exp Hematol. 1985 Oct;13(9):932-6.
6
Acute myelogenous leukaemia modulated by B12 deficiency: a case with bone marrow blast cell assay corroboration.由维生素B12缺乏引起的急性髓细胞白血病：一例经骨髓原始细胞检测证实的病例
Br J Haematol. 1984 Sep;58(1):91-4. doi: 10.1111/j.1365-2141.1984.tb06062.x.
7
Reliability and consistency of bone marrow assessments of complete remission in acute myelogenous leukaemia.急性髓性白血病完全缓解时骨髓评估的可靠性和一致性
Hematol Oncol. 1987 Apr-Jun;5(2):139-45. doi: 10.1002/hon.2900050208.
8
Comparison of tritiated thymidine labeling and suicide indices in acute nonlymphocytic leukemia.急性非淋巴细胞白血病中氚标记胸腺嘧啶核苷标记与自杀指数的比较
Cancer Res. 1978 Nov;38(11 Pt 1):3681-4.
9
Review of recent studies of cellular proliferation in acute leukemia.急性白血病细胞增殖的近期研究综述。
Natl Cancer Inst Monogr. 1969 May;30:81-120.
10
RNA and protein synthesis in proliferating and non-proliferating blast cells of human acute leukaemia.人类急性白血病增殖和非增殖母细胞中的RNA与蛋白质合成
Acta Haematol. 1971;45(2):82-8. doi: 10.1159/000208610.
引用本文的文献
1
Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后高危骨髓增生异常综合征微小残留病导向免疫治疗。
Front Med. 2019 Jun;13(3):354-364. doi: 10.1007/s11684-018-0665-5. Epub 2019 Jun 11.
2
Interferon-α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study.干扰素-α 对异基因造血干细胞移植后 t(8;21) 急性髓系白血病患者微小残留病的治疗有效：一项前瞻性登记研究的结果。
Oncologist. 2018 Nov;23(11):1349-1357. doi: 10.1634/theoncologist.2017-0692. Epub 2018 Aug 3.
3
Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation.干扰素-α 挽救治疗对异基因造血干细胞移植后微小残留病灶导向供者淋巴细胞输注反应不佳的急性白血病/骨髓增生异常综合征患者有效。
Front Med. 2019 Apr;13(2):238-249. doi: 10.1007/s11684-017-0599-3. Epub 2018 Apr 14.
本文引用的文献
1
A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion.人淋巴母细胞干扰素持续静脉输注的I期研究。
Cancer Chemother Pharmacol. 1982;9(2):97-102. doi: 10.1007/BF00265387.
2
Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML).人淋巴母细胞干扰素治疗急性髓性白血病（AML）的经验。
Cancer Chemother Pharmacol. 1983;11(1):56-8. doi: 10.1007/BF00257419.
3
Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations.干扰素与细胞分裂。一、干扰素制剂对小鼠白血病L 1210细胞体外增殖的抑制作用。
Proc Natl Acad Sci U S A. 1970 Aug;66(4):1052-8. doi: 10.1073/pnas.66.4.1052.
4
Growth inhibitory effects of interferon on normal and malignant human haemopoietic cells.干扰素对正常和恶性人类造血细胞的生长抑制作用。
Int J Cancer. 1977 Oct 15;20(4):500-5. doi: 10.1002/ijc.2910200405.
Zotero 插件